Pieces Technologies 8345 Stemmons Freeway, Suite 1150Dallas, TX 75247214-617-2320http://www.piecestech.com/ Key contact Name Title Ruben Amarasingham CEO DALLAS, TX, Pieces Technologies announced today that it has closed a $25.7 million Series B funding round. Pieces Technologies ("Pieces" or the "Company"), a healthcare artificial intelligence and technology company that connects health systems and the community to address […]
Archivio Categoria: venture capital funding
Vecna Robotics Waltham, MA617-444-9263https://www.vecnarobotics.com/ Key contact Name Title Daniel Theobald Founder & CEO WALTHAM, MA, Vecna Robotics, the leading workflow orchestration and self-driving forklift provider, announced it raised $50 million in Series B funding. With double-digit annual growth forecast for the mobile robot market over the next five years, the new capital will expand Vecna […]
Aegle Therapeutics 1951 NW 7th AveMiami, FL 33136www.aegletherapeutics.com Key contact Name Title Shelley A. Hartman CEO MIAMI, FL, Aegle Therapeutics today announced the closing of a $4M financing. Aegle Therapeutics, a first in class biotechnology company isolating extracellular vesicles, including exosomes ("EVs"), secreted by mesenchymal stem cells as therapy, today announced the closing of a […]
Cerebral Therapeutics 12635 E. Montview Blvd.Aurora, CO 80010303-547-3448cerebraltherapeutics.com Key contact Name Title Dan Abrams, M.D. CEO AURORA, CO, Cerebral Therapeutics, a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, announced today a $35 million Series B financing. The round was led by RA Capital Management, with participation from additional new investor Perceptive Advisors […]
RootPath 325 Vassar St. STE 2ACambridge, MA 02139http://www.rootpath.com/ Key contact Name Title Xi Chen CEO & Co-Founder CAMBRIDGE, MA, Preclinical-stage biotechnology company announced a $11 million Series A funding round. RootPath, a preclinical-stage biotechnology company aiming to enable personalized, highly-potent T cell therapy powered by its proprietary Synthetic Immunology Platform™, today announced a $11 million […]
Slayback Pharma 301 Carnegie Center, #303Princeton, NJ 08540609-945-3443http://www.slayback-pharma.com/ Key contact Name Title Ajay Singh CEO PRINCETON, NJ, Slayback Pharma announced an agreement with The Everstone Group to invest up to US$50 million in Series B funding. Slayback Pharma LLC ("Slayback") today announced an agreement with The Everstone Group ("Everstone") to invest up to US$50 million […]
Edquity 370 Jay St,Brooklyn, NY 11201513-781-9766https://edquity.co/ Key contact Name Title David Helene CEO BROOKLYN, NY, Edquity has secured an oversubscribed $2.4MM seed financing round. Edquity, a Brooklyn-based student financial success and emergency aid company, announced today that it has secured an oversubscribed $2.4MM seed financing round to expand its emergency cash grant and social services […]
OWYN 100 Passaic Ave #100Fairfield, NJ 07004833-533-7061https://liveowyn.com/ Key contact Name Title Mark Olivieri President FAIRFIELD, NJ, OWYN announced a growth investment round led by PowerPlant Ventures. OWYN™ (Only What You Need), a leading brand in plant-based protein beverages and other functional nutrition products, today announced a growth investment round led by PowerPlant Ventures ("PowerPlant"). Terms […]
TypingDNA 81 Prospect St.Brooklyn, NY 11201617-752-2956https://www.typingdna.com/ Key contact Name Title Raul Popa CEO NEW YORK, NY, Behavioral-biometrics company TypingDNA has announced that it raised a $7 million Series A round led by Gradient Ventures. Behavioral-biometrics company TypingDNA announces today that it raised a $7 million Series A round led by Gradient Ventures, Google's AI-focused venture […]
venture capital funding
FEI e Cassa Depositi e Prestiti Continuare A Collaborare Per rilanciare l’Economia italiana
03
Gen
Gen
ITALIA – Nel mese di dicembre 2019, il Fondo Europeo per gli Investimenti e Cassa Depositi e Prestiti riaffermato la loro cooperazione per sostenere le Pmi italiane, Mid-cap e start-up. Il co-investimento accordo è stato firmato dal FEI e Fondo Italiano d’Investimento sgr, di cui CDP è azionista di maggioranza, il supporto del private equity […]